These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 23722161)
1. Target-selective photo-degradation of verotoxin-1 and reduction of its cytotoxicity to Vero cells using porphyrin-globotriose hybrids. Okochi A; Tanimoto S; Takahashi D; Toshima K Chem Commun (Camb); 2013 Jul; 49(54):6027-9. PubMed ID: 23722161 [TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues. Watanabe M; Igai K; Matsuoka K; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K Infect Immun; 2006 Mar; 74(3):1984-8. PubMed ID: 16495579 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli. Li X; Wu P; Cheng S; Lv X J Med Chem; 2012 Mar; 55(6):2702-10. PubMed ID: 22372889 [TBL] [Abstract][Full Text] [Related]
4. Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid. Tanimoto S; Sakai S; Matsumura S; Takahashi D; Toshima K Chem Commun (Camb); 2008 Nov; (44):5767-9. PubMed ID: 19009075 [TBL] [Abstract][Full Text] [Related]
5. Photodegradation of amyloid β and reduction of its cytotoxicity to PC12 cells using porphyrin derivatives. Hirabayashi A; Shindo Y; Oka K; Takahashi D; Toshima K Chem Commun (Camb); 2014 Aug; 50(67):9543-6. PubMed ID: 25012260 [TBL] [Abstract][Full Text] [Related]
6. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Khine AA; Tam P; Nutikka A; Lingwood CA Glycobiology; 2004 Aug; 14(8):701-12. PubMed ID: 15102715 [TBL] [Abstract][Full Text] [Related]
7. Target-selective degradation of proteins by porphyrins upon visible photo-irradiation. Tanimoto S; Matsumura S; Toshima K Chem Commun (Camb); 2008 Aug; (31):3678-80. PubMed ID: 18665297 [TBL] [Abstract][Full Text] [Related]
8. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728 [TBL] [Abstract][Full Text] [Related]
9. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818 [TBL] [Abstract][Full Text] [Related]
10. Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone-sialic acid hybrids. Aoki Y; Tanimoto S; Takahashi D; Toshima K Chem Commun (Camb); 2013 Feb; 49(12):1169-71. PubMed ID: 23282898 [TBL] [Abstract][Full Text] [Related]
11. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. Arbus GS Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954 [TBL] [Abstract][Full Text] [Related]
12. Degradation of target oligosaccharides by anthraquinone-lectin hybrids with light switching. Imai Y; Hirono S; Matsuba H; Suzuki T; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K Chem Asian J; 2012 Jan; 7(1):97-104. PubMed ID: 21997955 [TBL] [Abstract][Full Text] [Related]
13. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341 [TBL] [Abstract][Full Text] [Related]
14. Molecular design, chemical synthesis, and biological evaluation of agents that selectively photo-degrade the transcription factor estrogen receptor-α. Tsumura K; Suzuki A; Tsuzuki T; Tanimoto S; Kaneko H; Matsumura S; Imoto M; Umezawa K; Takahashi D; Toshima K Org Biomol Chem; 2011 Sep; 9(18):6357-66. PubMed ID: 21789304 [TBL] [Abstract][Full Text] [Related]
15. [A case of hemolytic-uremic syndrome associated with urinary infection caused by Escherichia coli producing verotoxin]. Miédougé M; Watine J; Hacini J; Grimont F Ann Biol Clin (Paris); 1999; 57(6):727-9. PubMed ID: 10572225 [No Abstract] [Full Text] [Related]
16. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives. Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732 [TBL] [Abstract][Full Text] [Related]